Glenmark Pharma gets USFDA nod for generic drug
The company's US-based subsidiary has received final approval from the
US Food and Drug Administration (USFDA) for the product which is a
generic version of PF Prism CV's Rapamune tablets, Glenmark
Pharmaceuticals said in a statement.
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/glenmark-pharma-gets-usfda-nod-for-generic-drug/articleshow/78742920.cms
US Food and Drug Administration (USFDA) for the product which is a
generic version of PF Prism CV's Rapamune tablets, Glenmark
Pharmaceuticals said in a statement.
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/glenmark-pharma-gets-usfda-nod-for-generic-drug/articleshow/78742920.cms
Comments
Post a Comment